Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

CLINDAMYCIN PHOSPHATE AND TRETINOIN

CLINDAMYCIN PHOSPHATE; TRETINOIN

Standard Dose
1.2%;0.025%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PHOSPHATE AND TRETINOIN is listed in Drugs@FDA under application 216943 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE; TRETINOIN Form and strength GEL;TOPICAL - 1.2%;0.025% Sponsor ENCUBE Submission history Latest submission status date: 2023-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PHOSPHATE AND TRETINOIN is listed in Drugs@FDA under application 216943 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PHOSPHATE; TRETINOIN Form and strength GEL;TOPICAL - 1.2%;0.025% Sponsor ENCUBE Submission history Latest submission status date: 2023-09-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.